Latest news

Thumbnail image for Shire’s Intuniv hits targets in adult ADHD trial

Shire’s Intuniv hits targets in adult ADHD trial

Data from a Phase III study evaluating Shire’s Intuniv in Japan in adults with attention deficit hyperactivity disorder indicate that the drug could improve symptoms of the condition in this patient group.

20th September 2017

Thumbnail image for EU green light for Novartis’ Rydapt

EU green light for Novartis’ Rydapt

The European Commission has approved Novartis’ Rydapt to treat a certain form of acute myeloid leukaemia (AML) as well as three other rare diseases.

20th September 2017

Thumbnail image for NICE backs use of Opdivo for lung cancer

NICE backs use of Opdivo for lung cancer

Bristol-Myers Squibb’s Opdivo is being recommended by the National Institute for Health and Care Excellence to treat a certain form of lung cancer on the NHS in England, via the Cancer Drugs Fund.

20th September 2017

Thumbnail image for GSK, Innoviva announce US nod for Trelegy Ellipta

GSK, Innoviva announce US nod for Trelegy Ellipta

GlaxoSmithKline and Innoviva have bagged a green light in the US for the novel triple therapy inhaler Trelegy Ellipta, opening the door to a new treatment option for patients with Chronic Obstructive Pulmonary Disorder (COPD).

19th September 2017

Thumbnail image for Bavarian Nordic hit by cancer immunotherapy failure

Bavarian Nordic hit by cancer immunotherapy failure

Bavarian Nordic saw its shares plummet as much as 50 percent in the wake of news that the firm’s cancer immunotherapy ProstVac failed to prolong survival in men with a particular type of prostate cancer.

18th September 2017

Thumbnail image for NICE rejects first-line use of Roche’s Gazyvaro

NICE rejects first-line use of Roche’s Gazyvaro

The National Institute for Health and Care Excellence has turned down first-line use of Roche’s Gazyvaro in patients with untreated advanced follicular lymphoma on the NHS in England and Wales.

18th September 2017

Previous  --   1 2 3 4 5 6 7 8 9 10   --  Next

Latest jobs

View all

Download our apps

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Download